Chronic Pain  >>  Symproic (naldemedine)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Symproic (naldemedine) / Shionogi, Collegium Pharma
NCT01122030: Study to Evaluate the Safety and Efficacy of Naldemedine (S-297995) for the Treatment of Opioid-Induced Bowel Dysfunction in Subjects With Chronic Pain

Completed
2
72
US
Naldemedine, S-297995, Symproic®, Placebo
Shionogi
Opioid Induced Bowel Dysfunction
02/11
03/11
NCT01443403: A Study of Naldemedine (S-297995) for the Treatment of Opioid-Induced Constipation in Adults With Non-Malignant Chronic Pain Receiving Opioid Therapy

Completed
2
244
US
Placebo, Naldemedine, S 297995, Symproic®
Shionogi
Opioid-induced Constipation
08/12
08/12

Download Options